- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 53,613,124
- Share change
- +22,085,099
- Total reported value
- $268,022,905
- Put/Call ratio
- 121%
- Price per share
- $5.00
- Number of holders
- 119
- Value change
- +$97,310,967
- Number of buys
- 70
- Number of sells
- 73
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bellevue Group AG |
13F
|
Company |
1.7%
|
4,519,164
|
$54,455,000 | — | 30 Sep 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
1.3%
|
3,274,360
|
$39,456,000 | — | 30 Sep 2021 | |
| Meditor Group Ltd |
13F
|
Company |
1.1%
|
2,818,835
|
$33,967,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.78%
|
2,006,134
|
$24,173,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.71%
|
1,840,243
|
$22,175,000 | — | 30 Sep 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.66%
|
1,713,176
|
$20,644,000 | — | 30 Sep 2021 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.24%
|
622,267
|
$7,498,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
577,281
|
$6,956,000 | — | 30 Sep 2021 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.2%
|
520,095
|
$6,268,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
467,298
|
$5,631,000 | — | 30 Sep 2021 | |
| BIOTECH TARGET N V |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,477,964
|
$5,575,065 | — | 24 May 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.17%
|
451,789
|
$5,444,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
341,871
|
$4,119,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
294,842
|
$3,553,000 | — | 30 Sep 2021 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.11%
|
293,766
|
$3,540,000 | — | 30 Sep 2021 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.1%
|
260,959
|
$3,145,000 | — | 30 Sep 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.1%
|
259,068
|
$3,122,000 | — | 30 Sep 2021 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
256,761
|
$3,094,000 | — | 30 Sep 2021 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.1%
|
254,774
|
$3,070,027 | — | 30 Sep 2021 | |
| Swedbank AB |
13F
|
Company |
0.08%
|
217,000
|
$2,614,850 | — | 30 Sep 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
184,684
|
$2,225,000 | — | 30 Sep 2021 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
169,400
|
$2,041,000 | — | 30 Sep 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.06%
|
146,943
|
$1,771,000 | — | 30 Sep 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.05%
|
131,849
|
$1,589,000 | — | 30 Sep 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.05%
|
125,953
|
$1,518,000 | — | 30 Sep 2021 | |
| PDT Partners, LLC |
13F
|
Company |
0.05%
|
120,828
|
$1,456,000 | — | 30 Sep 2021 | |
| LINDEN ADVISORS LP |
13F
|
Company |
0.05%
|
116,827
|
$1,408,000 | — | 30 Sep 2021 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
115,200
|
$1,388,000 | — | 30 Sep 2021 | |
| Cinctive Capital Management LP |
13F
|
Company |
0.04%
|
110,558
|
$1,332,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
103,967
|
$1,253,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
98,114
|
$1,226,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.04%
|
101,580
|
$1,224,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.04%
|
94,505
|
$1,137,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
92,049
|
$1,109,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
86,455
|
$1,041,000 | — | 30 Sep 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.03%
|
85,818
|
$1,034,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
77,147
|
$929,000 | — | 30 Sep 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
72,499
|
$874,000 | — | 30 Sep 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.03%
|
70,571
|
$850,000 | — | 30 Sep 2021 | |
| Walleye Trading LLC |
13F
|
Company |
0.03%
|
70,324
|
$847,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
68,083
|
$821,000 | — | 30 Sep 2021 | |
| ARISTEIA CAPITAL, L.L.C. |
13F
|
Company |
0.03%
|
67,693
|
$816,000 | — | 30 Sep 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.02%
|
63,460
|
$765,000 | — | 30 Sep 2021 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.02%
|
60,927
|
$734,000 | — | 30 Sep 2021 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.02%
|
55,338
|
$667,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
52,400
|
$631,000 | — | 30 Sep 2021 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
0.02%
|
49,973
|
$602,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
49,575
|
$597,000 | — | 30 Sep 2021 | |
| VIRGINIA RETIREMENT SYSTEMS ET Al |
13F
|
Company |
0.02%
|
48,800
|
$588,000 | — | 30 Sep 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
48,606
|
$585,000 | — | 30 Sep 2021 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2021
As of 31 Dec 2021,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,613,124 shares.
The largest 10 holders included
WASATCH ADVISORS INC, Deep Track Capital, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Bellevue Group AG, Meditor Group Ltd, VANGUARD GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, Altium Capital Management LP, BlackRock Inc., and CVI Holdings, LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
133
Q4 2021 holders
119
Holder diff
-14
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.